Trials / Completed
CompletedNCT00583791
Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 91 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective is to investigate the safety of the AMPLATZER Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are hemodynamically significant and are either isolated or in conjunction with other congenital heart defects in infants and children.
Detailed description
The objective of this feasibility study is to investigate the safety of the AMPLATZER Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are hemodynamically significant and are either isolated or in conjunction with other congenital heart defects in infants and children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Device closure with the AMPLATZER Muscular VSD Occluder | Device: AMPLATZER Muscular VSD Occluder |
Timeline
- Start date
- 2000-07-01
- Primary completion
- 2008-10-01
- Completion
- 2009-11-01
- First posted
- 2007-12-31
- Last updated
- 2019-06-28
- Results posted
- 2019-06-28
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00583791. Inclusion in this directory is not an endorsement.